![William Enright](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Enright
Directeur Général chez
BARINTHUS BIOTHERAPEUTICS PLC
Fortune : 852 662 $ au 31/05/2026
Profil
William Enright is currently Chief Executive Officer & Director at Barinthus Biotherapeutics (UK) Ltd. since 2019, Chief Executive Officer & Director at Barinthus Biotherapeutics Plc since 2019, Director at Gravitas Therapeutics, Inc. since 2022, and Independent Non-Executive Director at BullFrog AI Holdings, Inc. since 2023.
Formerly, Mr. Enright was President, Chief Executive Officer & Director at Altimmune, Inc. from 2008 to 2018, Director-Research & Development at Wellstat Biologics Corp.
from 1996 to 2010, Head-Business Development at GenVec, Inc., Scientist at State University of New York at Buffalo, Principal at Life Technologies Corp., and Chief Scientific Officer at ImQuest BioSciences, Inc. Education includes undergraduate and graduate degrees from State University of New York at Buffalo and a graduate degree from The Johns Hopkins University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 1 243 377 ( 3,15% ) | 846 740 $ | 31/05/2026 | |
| 11/06/2026 | 7 813 ( 0,04% ) | 5 922 $ | 31/05/2026 |
Postes actifs de William Enright
| Sociétés | Poste | Début |
|---|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Directeur Général | 01/08/2019 |
| BULLFROG AI HOLDINGS, INC. | Directeur/Membre du Conseil | 14/02/2023 |
Vaccitech (UK) Ltd.
 Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Directeur Général | 28/08/2019 |
Gravitas Therapeutics, Inc.
 Gravitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical-stage antifungal for treatment of aspergillus mold infections | Directeur/Membre du Conseil | 01/01/2022 |
Anciens postes connus de William Enright
| Sociétés | Poste | Fin |
|---|---|---|
| ALTIMMUNE, INC. | Directeur Général | 30/11/2018 |
Wellstat Biologics Corp.
 Wellstat Biologics Corp. Pharmaceuticals: MajorHealth Technology Operates as development and commercialization of biological agents | Directeur Technique/Scientifique/R&D | 01/10/2010 |
ImQuest BioSciences, Inc.
 ImQuest BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates preclinical contract research and development organization for biotechnology and pharmaceutical industries | Directeur Technique/Scientifique/R&D | - |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Corporate Officer/Principal | - |
Formation de William Enright
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
State University of New York at Buffalo
State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Wellstat Biologics Corp.
Wellstat Biologics Corp. Pharmaceuticals: MajorHealth Technology Operates as development and commercialization of biological agents | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImQuest BioSciences, Inc.
ImQuest BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates preclinical contract research and development organization for biotechnology and pharmaceutical industries | Commercial Services |
Altimmune, Inc.
 Altimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
BullFrog AI Holdings, Inc.
 BullFrog AI Holdings, Inc. Packaged SoftwareTechnology Services Develops an artificial intelligence and machine learning platform for clinical and pharmaceutical industry | Technology Services |
Vaccitech Plc
 Vaccitech Plc Pharmaceuticals: MajorHealth Technology Discovers and develops immunotherapeutic products and vaccines for the treatment and prevention of infectious and cancer diseases | Health Technology |
Gravitas Therapeutics, Inc.
Gravitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical-stage antifungal for treatment of aspergillus mold infections | Commercial Services |
